Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Notes Payables (2016 - 2017)

Sanara MedTech (SMTI) has disclosed Notes Payables for 7 consecutive years, with $1.2 million as the latest value for Q4 2017.

  • For the quarter ending Q4 2017, Notes Payables rose 189.62% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Dec 2017, up 189.62%, and an annual FY2017 reading of $1.2 million, up 189.62% over the prior year.
  • Notes Payables was $1.2 million for Q4 2017 at Sanara MedTech, up from $223500.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $1.2 million in Q4 2017 and bottomed at $50000.0 in Q2 2016.
  • Average Notes Payables over 4 years is $433198.3, with a median of $414338.0 recorded in 2016.
  • The sharpest move saw Notes Payables tumbled 32.6% in 2016, then skyrocketed 347.0% in 2017.
  • Year by year, Notes Payables stood at $415620.0 in 2013, then soared by 47.9% to $614700.0 in 2015, then crashed by 32.6% to $414338.0 in 2016, then surged by 189.62% to $1.2 million in 2017.
  • Business Quant data shows Notes Payables for SMTI at $1.2 million in Q4 2017, $223500.0 in Q3 2017, and $223500.0 in Q2 2017.